Senior insider sale
Chief Medical Officer at DENALI THERAPEUTICS INC. — senior position signals high conviction
$6.50M
300K shares
What this filing means
HO CAROLE plans to sell 300K shares of DENALI THERAPEUTICS INC. valued at approximately $6.50M. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 2/4/2026ACC: 0001950047-26-000923
Officer· Chief Medical Officer
Since Aug 2018
300K
Shares to sell
$6.50M
Approx. market value
150K
Acquired (3 months)
1
Planned
1 completed
Securities Acquired — Last 3 Months2
Exercise of options under a registered plan
Cash
2/4/2026
113.96KExercise of options under a registered plan
Cash
2/4/2026
36.04KTotal acquired150K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
2/4/2026 | Exercise of options under a registered plan Cash | 113.96K | — |
2/4/2026 | Exercise of options under a registered plan Cash | 36.04K | — |
| Total | 150K | ||
Planned & Completed Dispositions2
Completed
—Completed
Units to sell
150K
Market value
$3.32M
2/3/2026
Planned — Approximate Date
NASDAQPlanned
Units to sell
150K
Market value
$3.18M
2/4/2026
Total
Units
300K
Value
$6.50M
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
| Completed | ||||
2/3/2026 | 150K | $3.32M | — | Completed |
| Planned — Approximate Date | ||||
2/4/2026 | 150K | $3.18M | NASDAQ | Planned |
| Total | 300K | $6.50M | ||